Results for tag: "Acute Lymphoblastic Leukemia"

Acute Lymphoblastic Leukemia (ALL) is a type of cancer that affects the white blood cells in the body. It is the most common type of cancer in children, but can also affect adults. ALL is caused by an overproduction of immature white blood cells, which can crowd out healthy cells and interfere with the body’s ability to fight infection. Treatment for ALL typically involves chemotherapy, radiation, and/or stem cell transplantation. The ALL market is a subset of the larger oncology market, which is estimated to reach $150 billion by 2026. The ALL market is expected to grow at a steady rate due to the increasing prevalence of the disease and the development of new treatments. Several companies are involved in the ALL market, including Novartis, Pfizer, Amgen, and Celgene. These companies are involved in the development and marketing of treatments for ALL, such as chemotherapy drugs, targeted therapies, and immunotherapies. Show Less Read more